ImmunityBio, Inc. (IBRX)
2.30
+0.08
(+3.60%)
USD |
NASDAQ |
Dec 10, 16:00
2.30
0.00 (0.00%)
After-Hours: 20:00
ImmunityBio Shareholders Equity (Quarterly): -524.32M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Hims & Hers Health, Inc. | 580.98M |
| Regeneron Pharmaceuticals, Inc. | 30.96B |
| Anixa Biosciences, Inc. | 16.60M |
| Iovance Biotherapeutics, Inc. | 702.29M |
| Summit Therapeutics, Inc. | 192.26M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 518.99M |
| Total Liabilities (Quarterly) | 1.042B |
| Debt to Equity Ratio | -1.643 |
| Current Ratio | 5.767 |
| Net Debt Paydown Yield | 1.14% |